PURINE DERIVATIVES AS A2B ADENOSINE RECEPTOR ANTAGONISTS

Details for Australian Patent Application No. 2002320199 (hide)

Owner CV THERAPEUTICS, INC.

Inventors VARKHEDKAR, Vaibhav; ZABLOCKI, Jeff, A.; XIAO, Dengming; PALLE, Venkata

Pub. Number AU-A-2002320199

PCT Number PCT/US02/20631

PCT Pub. Number WO2003/002566

Priority 60/302,208 29.06.01 US

Filing date 27 June 2002

Wipo publication date 3 March 2003

International Classifications

C07D 473/16 Heterocyclic compounds containing purine ring systems

A61K 031/52

A61P 035/00 Antineoplastic agents

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/302,208 29.06.01 US

15 May 2003 Application Open to Public Inspection

  Published as AU-A-2002320199

18 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002320200-Tagetes erecta marigolds with altered carotenoid compositions and ratios

2002320198-New assays for preimplantation factor and preimplantation factor peptides